On April 5,2024, Archon Capital Management announced that it has engaged, and intend to continue to engage, in communications with the Apyx Medical Corporation?s Board of Directors and management team regarding means of increasing stockholder value at the Company, including by enhancing the Board through the addition of well-qualified directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -2.10% | -6.67% | -46.56% |
Apr. 05 | Archon Capital Management Engages with Apyx Medical Corporation | CI |
Apr. 01 | Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.56% | 49.54M | |
-3.35% | 184B | |
-2.22% | 107B | |
-4.18% | 67.78B | |
+0.76% | 50.66B | |
+10.56% | 47.64B | |
+4.60% | 41.12B | |
+0.59% | 26.3B | |
+1.26% | 26.04B | |
+15.06% | 25.4B |
- Stock Market
- Equities
- APYX Stock
- News Apyx Medical Corporation
- Archon Capital Management Engages with Apyx Medical Corporation